Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation.
Emma C Hart, Nisha Charkoudian, B Gunnar Wallin...
https://pubmed.ncbi.nlm.nih.gov/19171792Actively Recruiting
Led by University of Alberta · Updated on 2026-01-08
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how resting blood pressure control differs between healthy males and females. The study focuses on the communication between the sympathetic nervous system, which controls the "fight or flight" response, and blood vessels that affect systemic blood pressure. It also examines how specific blood vessel receptors, called alpha and beta-adrenergic receptors, respond to sympathetic signals and whether their behavior differs by sex. Understanding these differences may help explain why blood pressure regulation varies between males and females. Participants will attend one approximately 3-hour study visit where they receive small doses of medications through a catheter in the arm to test blood vessel responses. These medications include blockers to alpha- and beta-adrenergic receptors, given alone or together, as well as agents that stimulate these receptors. During the visit, saline infusions control for volume effects. The study measures forearm blood flow and vascular resistance under different conditions with receptor blockades. During the visit, participants have blood samples taken to measure sex hormones and sympathetic neurotransmitters. Their muscle sympathetic nerve activity is recorded using fine needles in the leg. Blood pressure, heart rate, and forearm blood flow are monitored using ultrasound. The main outcomes measured include forearm blood flow, vascular resistance, vascular conductance, arterial blood pressure, muscle sympathetic nerve activity, and circulating hormone levels. The total study participation is a single visit, and safety is closely monitored throughout.
CONDITIONS
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 day
Participants receive incremental doses of various drugs via a brachial artery catheter to assess adrenergic receptor function and vascular responses under different blockade conditions.
1 in-person study visit with multiple drug administration conditions
Total: 1 location
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2R3
Actively Recruiting
E
Emily Vanden Berg, MSc
N
Nicholas Cheung, MSc
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Emma C Hart, Nisha Charkoudian, B Gunnar Wallin...
https://pubmed.ncbi.nlm.nih.gov/19171792Craig D Steinback, Graham M Fraser, Charlotte W Usselman...
https://pubmed.ncbi.nlm.nih.gov/31106429Seth T Fairfax, Seth W Holwerda, Daniel P Credeur...
https://pubmed.ncbi.nlm.nih.gov/23652594Frank A Dinenno, John H Eisenach, Niki M Dietz...
https://pubmed.ncbi.nlm.nih.gov/11986395Sarah L Hissen, Chloe E Taylor
https://pubmed.ncbi.nlm.nih.gov/32865664